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Refolding of the heavy chain of the Class I HLA molecule, HLA-B27, in the absence of β2m, yields soluble high molecular weight (HMW)
oligomers reminiscent of the oligomeric forms of β2m-free heavy chains (FHCs) of class I HLA antigens observed on cell surfaces. Here we
examine the structural characteristics of HMW B27 in respect of features potentially relevant to autoimmunity, such as: (a) retention of native-like
structure, since this could facilitate non-canonical interactions with T-cell receptors even in the absence of bound β2m and peptide, or (b) presence
of non-native structure, since this could yield novel (non-self) antigenic conformational epitopes that could elicit immune attack. We report that
HMW B27 is characterized by high secondary structural content, structural stability, stability to proteolysis by trypsin, and structural features that
are both partly native-like, and partly non-native-like, as assessed through the binding of conformationally-distinguishing and cross-reacting scFv
antibodies specifically selected against HMW B27. We also present cell ELISA data with conformation-specific scFv antibodies that distinguish
between lymphocytes from individuals who are healthy and B27 positive, and those who are B27 positive but suffering from ankylosing
spondylitis.
© 2007 Elsevier B.V. All rights reserved.Keywords: HLA-B27; MHC dysfunction; Protein misfolding; Cross-display; Secondary structure; Thermal stability; Autoimmunity1. Introduction
MHCClass I heavy chains have classically been known to be
unfolded and degraded in the absence of bound β2m [1]. During
the last decade, however, data have emerged to suggest that
β2m-free heavy chains (FHC) exist on the surfaces of all MHC
class I-expressing cells and, in particular, on the surfaces of
activated lymphocytes, transformed lymphoblasts, fibroblasts
and neuroblastoma cell lines [2–7]. Cell-surface FHCs have
been reported to show relatively long half-lives of several hoursAbbreviations: MHC, major histocompatibility complex; HLA, human
leucocyte antigen; HMW, high molecular weight; TC, ternary complex; scFv,
single chain variable fragment
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doi:10.1016/j.bbadis.2007.10.005[4]. Of course, the functional role played by such FHCs, if any,
remains to be discovered. Even so, what is known already is that
FHCs tend to cluster, or oligomerize, on cell surfaces [6,8]. It
has been suggested that these clusters may be HLA sinks
that act as sources of soluble HLA, through cleavage by
metalloproteinases [9]. It has also been suggested that FHCs
may perform some sort of an immunomodulatory role [10].
Of the various types of class I HLA molecules, one that has
been specifically observed and examined both in vitro and in
vivo in the absence of β2m is HLA-B27. Disulfide-bonded
homodimers of β2m-free HLA-B27 have been shown to form in
vitro [11], and have also been detected on the cell surface and in
the endoplasmic reticulum [12–14]. Structurally-distorted
peptide-binding clefts retained within such β2m-free B27
homodimers have been suggested to bind and display peptides
to γ and δ chain TCRs [15]. Separately, a particular subtype of
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cell surface in a β2m-free but peptide-bound state [16].
In addition to homodimers, B27 chains have also been
observed to form soluble highmolecular weight (HMW) forms in
vitro. Indeed, the bulk of any B27 heavy chain population
undergoing folding in the absence of β2m tends to adopt HMW
forms, with disulfide-bonded homodimers constituting only a
minority population [11]. Still, homodimeric B27 has attracted the
larger share of research attention, presumably because the HMW
forms have commonly been taken to be simply aggregates that are
intractable to conventional structural-biochemical analyses. It
appears, therefore, that whereas a whole new paradigm could be
taking shape in relation to our understanding of the structure- and
function-related behavior ofβ2m-free HLA chains in general, and
β2m-free HLA-B27, in particular, there remains a lacuna in our
knowledge concerning HMW forms despite occasional com-
ments about the possibility of this form being structured [11].
Assuming that HMW oligomers observed in vitro could be
analogs of FHC oligomeric clusters seen in vivo, and given that
FHCs are ubiquitous and clearly somehow functionally im-
portant, we considered it important to create and examine HMW
B27 through biophysical and biochemical investigations, to
focus attention on HMW B27, a molecule typically associated
with autoimmune disease, and see: (i) whether it is structured
and conformationally stable, and (ii) examine it in relation to its
native-like and non-native-like structural content, with a view to
exploring potential diagnostic indicators of misfolding asso-
ciated with disease.
2. Materials and methods
2.1. Genetic manipulations
A vector expressing HLA-B2705 (plasmid pLM1-HLA-B27, encoding the
extracellular domain of HLA-B27) was obtained as a gift fromDr. D. N. Garboczi
(NIH, USA). We modified the vector genetically to engineer the inclusion of an
N-terminal 6xHis tag in genetic fusion with the gene encoding HLA-B27, to
create a modified vector, pHisB27, as follows: The gene encoding extracellular
B2705 was amplified using the primers 5′-TATATTAATTAGAATTCAGGAG-
GAATTTAAAATGCATCACCATCACCATCACGGCTCT-3′ and 5′-GTAGG-
CGTCCTGGTGGTACCCGCGGAGG-3′ in a PCR reaction carried out under the
following conditions: denaturation for 3 min at 94 °C, followed by 25 cycles of
1 min denaturation at 94 °C, 1 min annealing at 46 °C, 2 min extension at 72 °C,
and then by a further 15 min of extension at 72 °C. This reaction amplified a
(380 bp) section of the gene, beginning at its 5′ end, terminating at a KpnI site
located 380 bp downstream of its 3′ end (in the plasmid pLM1-HLA-B27), and
introducing new codons encoding 6 contiguous histidine residues immediately
5′ of the original codon encoding the first residue. The product thus obtained was
digested with EcoR1 and Kpn1 and cloned between the same two sites on a
double-digested plasmid pLM1-HLA-B27. This plasmid, renamed pHisB2705,
was then transformed into E. coli BL21(DE3)pLys, and clones containing inserts
(and producing protein upon induction with IPTG) were identified through SDS-
PAGE analysis. A protein-producing clone was subjected to DNA sequencing on
anAppliedBiosystems 310 Prism automated sequencer to verify the sequence and
the correct incorporation of the 6xHis residues at the N terminus of the protein.
Similarly, the DNA encoding human β2-microglobulin was subcloned from
the vector (pc DNA 3.1) obtained as a gift from Dr. F. Greten, Germany, and
modified to incorporate a 6xHis tag. Using primers, 5′-GCTACCGCATGCAT-
CCAGCGTACTCCAAAGATTCAGG-3′ and 5′-GCTAGGAAGCTTTTACA-
TGTCTCG-3′, PCR was performed with the following program: 94 °C for 5 min,
followed by 25 cycles of 94 °C for 1 min, 60 °C for 1min, 72 °C for 1 min, with an
additional extension of 5 min at 72 °C. The PCR product of 356 bp was digestedwith Sph1 andHindIII and ligated into the vector pQE-30, pre-digested with Sph1
and HindIII and transformed into competent XL1-Blue E. coli; DNA sequencing
was done to confirm the integrity of the construct and further transformation of this
DNAwas carried out into competent M15-pREP4E. coli cells for overexpression.
2.2. Protein expression and purification
A 500 ml culture set up with an innoculum of cells transformed with
pHisB2705 was incubated at 37 °C, and induced to produce protein by addition
of IPTG (0.5 mM) at O.D600 of 0.4. Cells were harvested by centrifugation, and
the cell pellet was resuspended in 0.1MNaH2PO4, 0.01MTris–Cl, pH 8.0 buffer
containing 8 M urea. After stirring for 1 h at room temperature, the suspension
was centrifuged and the supernatant was loaded onto a Ni-NTA column pre-
equilibrated with the same buffer. Elution of bound protein was done with 0.1 M
NaH2PO4, 0.01 M Tris–Cl, pH 4.5 buffer containing 8 M urea. Refolding of the
protein was carried out by dialysis against progressively lower concentrations of
urea in 0.1 M NaH2PO4, 0.01 M Tris–Cl buffer, pH 8. This purified protein was
subjected to N-terminal sequencing on an ABI 377 protein sequencer, to confirm
chemical identity. β2m was expressed and purified in a similar manner.
2.3. Nondenaturing (native) polyacrylamide gel electrophoresis
HMW B27 samples were prepared for non-denaturing polyacrylamide gel
electrophoresis through treatment with various combinations of heat denatura-
tion (boiling or not boiling samples), SDS denaturation (addition, or omission,
of 1% SDS in the sample loading buffer), and reduction (addition, or omission,
of 5 mM DTT). There was no SDS included in the gel casting buffers or in the
running buffer used for electrophoresis.
2.4. Formation of complexes of HLA-B27 with β2m and peptide
Incubation of HLA-B27 heavy chain (HC), β2-microglobulin and peptide in
the molar ratio of 1:2:10 (31 μg/ml:24 μg/ml:10 μg/ml) was carried out in
100mMTris–Cl, 400mMArg, 2 mMEDTA, 0.5mMPMSF pH 8.0 at 10 °C, for
36–48 h, as described by earlier authors [17]. The peptide incorporated into the
complex was a nonameric peptide, N-KRWHMGLNK-C. As per the epitope
prediction program developed by Rammensee et al. (http://www.syfpeithi.de/)
[18], this peptide sequence is predicted to be capable of forming a high-affinity
complex with HLA-B27 and β2m, with a score of 26. This score falls at the
boundary of values [26–27] characterizing high-affinity binding peptides.
Analysis of complex formation, and purification of complexes was carried out by
gel filtration chromatography, using a Superdex 200 gel filtration column.
Separately, we subsequently also prepared complexes of B27 with two other high-
affinity binding peptides, N-KRWIIMGLNK-C and N-RRYLENGKETL-C.
2.5. Chromatography
The purified refolded B27 protein in soluble form, as well as control com-
plexes of B27 with β2-microglobulin and peptide, were analyzed through gel
filtration chromatography on a Superdex 200 column attached to a Pharmacia
SMART System, using 150 mM NaCl and 20 mM Tris-Cl buffer, pH 8.0 for
equilibration. The gel filtration experiment was repeated in the presence of DTT
(5 mM) to examine the presence of disulfide-bonded species.
2.6. Spectroscopy
UV-visible absorption spectra were collected on a Varian 50-Bio spectro-
meter. In the case of the HLA-B27, an absorbance of 2.07 at 280 nm (OD280) was
taken to indicate a concentration of 1 mg/ml as per the predicted extinction
coefficient. Similarly, in the case of β2m, an absorbance of 1.49 was taken to
indicate this concentration. A Perkin Elmer LS-50B spectrofluorimeter was used
to examine fluorescence characteristics, with excitation and emission band
passes of 5 nm each, with excitation being carried out at 280 nm, and with
monitoring of emission in the range of 300 to 400 nm. A Jasco J710
spectropolarimeter was used to collect CD spectra, at controlled temperatures,
through a peltier-based heating/cooling arrangement. In case of far-UV CD
measurements for HMW B27, scanning was done between 250 and 190 nm,
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The complex of HLA-B27 with β2m and peptide was scanned in the region of
250–200 nm, using a cuvette with path length of 0.1 cm. Thermal melting was
carried out by heating the proteins at a rate of either 2 or 3 °C/min, andmonitoring
changes in the CD signal at 222 nm, with cooling also performed using the same
temperature gradient. Measurement of the CD spectrum at 95 °C or 99 °C was
done after the samples were equilibrated at this high temperature for 5 min
(adequate for chemical, thermal and conformational equilibration of the sample).
2.7. Digestion of protein with trypsin
HLA-B27 was incubated with trypsin at 37 °C, using a trypsin: B27 molar
ratio of approximately 1:6000 for a period of 1, 2 and 3 h and one sample was
incubated overnight. The polypeptide fragment, found to be relatively resistant
to proteolysis was subjected to N-terminal sequencing on an ABI 377 sequencer.
2.8. ELISA of HMW B27
100μg/ml each ofHMWB27 aswell as the complexwere coated on an ELISA
plate; separately control proteins (BSA and ovalbumin) were also coated onto the
ELISAwells using solutions of the same concentrations.Mousemonoclonal w6/32
antibody (Abcam cat no. 23755) was used at a concentration of 1:30 (stock
concentration being 1 mg/ml). Anti-mouse HRP-labeled secondary antibody
(Sigma; 1:500 dilution) was used; TMB was used as the substrate.
2.9. Screening of scFv phages from phage library
Two phage-display human antibody scFv libraries (Tomlinson I and J,
procured from MRC, UK), constructed in fusion with the pIII protein of M13
filamentous phages, were used to screen for antibodies showing affinity to
HMW B27. First, immunotubes (Nunc) were coated with 4 ml of HMW B27 of
100 μg/ml concentration; the unbound protein was washed using PBS, followed
by blocking with 10% MPBS for 2 h. After 3 washes with PBS, 1012 phages of
the scFv I or J library were added to immunotubes and incubated for 60 min at
room temperature. PBS containing 0.1% Tween-20 was used for washing.
Bound phage was eluted with 500 μl of trypsin-PBS. E. coli TG1 was infected
with the eluted phages and an aliquot was serially diluted and plated on 2× TY
agar containing 1% glucose and 100 μg/ml ampicillin for titration of phages.Table 1
Details of the binding capabilities of the 20 selected clones from libraries I and J re
1 2 3 4 5 6
scFv ID Raised against HMW
ELISA (H)
Ternary complex
ELISA (TC)
HMW/complex
(H/TC)
Weste
blot+
I1H HMW 2.74 1.61 1.7:1 √
I2A HMW 2.78 0.35 8.0:1 √
I2C HMW 2.87 0.34 8.4:1 √
I2H HMW 2.69 0.25 10.7:1 √
I3A HMW 2.79 1.00 2.8:1 √
I3G HMW 2.68 0.20 13.4:1
I3H HMW 2.35 0.09 26.1:1 √
I4B HMW 2.61 0.33 7.8:1
I5A HMW 2.72 1.05 2.6:1
I9D HMW 2.36 0.278 8.8:1
I11E HMW 2.76 1.41 2.0:1 √
J1A HMW 2.31 0.32 7.2:1
J2A HMW 2.51 1.36 1.8:1 √
J2B HMW 2.85 0.76 3.8:1 √
J3E HMW 2.47 0.06 39.1:1 √
J3F HMW 2.61 1.00 2.6:1 √
J3H HMW 2.47 2.09 1.2:1 √
J5E HMW 2.76 0.98 2.8:1 √
J6F HMW 2.67 0.69 3.9:1 √
J8D HMW 2.06 0.19 11.0:1The remaining TG1 culture was centrifuged and the pelleted bacteria
resuspended in 50 μl of 2× TY and plated on a TYE plate containing 1%
glucose and 100 μg/ml ampicillin. Colonies were collected and resuspended in
2× TY/15% glycerol and used to prepare phage for the next round of selection.
Three rounds of such selection through ‘bio-panning’ were performed on the
HMW form of the HLA-B27 heavy chain. The recovery rate of the third round
bio-panning was close to that of the second round indicating that positive clones
were fully enriched and as expected, an enrichment within the range of 10–100
fold was observed after subsequent bio-panning. Monoclonal phage ELISAwas
performed with 96 clones as follows, to confirm whether phages obtained indeed
displayed B27-binding scFvs: After E. coli TG1 was infected with scFv phages
derived from the third round of bio-panning, and plated on 2× TY agar,
individual colonies were inoculated into a 96-well round-bottomed microtiter
plate, grown overnight, and phage prepared as previously described (http://
www.geneservice.co.uk/products/proteomic/datasheets/tomlinsonIJ.pdf). Then,
a 96-well flat-bottomed microtiter plate was coated with 100 μg/ml HLA-B27 in
PBS overnight at 4 °C. Excess protein was washed away thrice and the plate
blocked with milk-containing PBS for 2 h at 37 °C. A total of 150 μl of each
phage-containing supernatant was transferred to the HMW B27 coated plates
and incubated with shaking for 2 h at room temperature. The plate was washed
four times with PBS/0.1% (v/v) Tween-20 and four times with PBS. Then,
100 μl anti-M13/HRP monoclonal antibody (Amersham, UK) was added with
shaking to each well at 1:5000 dilution in 10% MPBS and incubated shaking at
room temperature for 1 h. The wells were washed with PBS/0.1% Tween-20 and
PBS before the use of a TMB substrate-peroxidase kit to visualize phage binding
through color development. Reactions were stopped by addition of 1 M sulfuric
acid and absorbance was measured at 450 nm with a background correction of
650 nm. Fig. S1 (Supplementary data) shows that most of the 96 scFv-
displaying phage clones selected from libraries I and J showed considerable
binding to HMW B27.
2.10. Monoclonal scFv ELISA
The selected phages from the 96 clones were used to infect HB2151 (a non-
suppressor strain). The phage genomes in this cell function as phagemids.
Induction with IPTG under standard conditions leads to expression of soluble
scFv antibody fragments, through the action of an amber-suppressor stop codon
placed between the scFv-encoding region and the phage pIII coat protein region,
within the fusion construct encoded by each phage genome. The expressedspectively
7 8 9 10
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Sequence epitope
H and TC
Sequence epitope
H only
Conf. epitope
H and TC
Conf. epitope
H only
√
√√
√√
√√
√
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√
√
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phagemid-containing population, and extract supernatants were used to perform
ELISA (with the HMW form of HLA-B27 coated on the wells of the ELISA
plate, as described above) and the detection of bound scFv was performed using
Protein-A HRP conjugate.
2.11. Cell-ELISA
Peripheral blood mononuclear cells (PBMCs: 100 μl of a suspension of
2×106cells/ml) were added to poly-L-lysine-coated wells in a 96-well plate.
After three washings with 1× PBS, cells were fixed using absolute methanol for
5 min at room temperature. Internal peroxides were inactivated by treatment
with 0.3% hydrogen peroxide in absolute methanol for 30 min. This was
followed by 3 washings with 1× PBS; wells containing cells were blocked by
using 5% BSA in 1× PBS overnight at 4 °C. Primary antibody (scFv) was added
into wells after washing with 1× PBS and incubated for 2 h at room temperature.
Mouse anti-His monoclonal antibody at a dilution of 1:1000 was added to each
well and incubated for 2 h. This was followed by incubation with anti-mouse
HRP-conjugated antibody (1:1000 dilution) for 1 h at room temperature. Color
was developed with TMB; the reaction was stopped with 1 N sulfuric acid, and
the plates were read at 450 nm.
2.12. Patients
Standard serological and DNA-based testing is utilized in our laboratory as
part of a routine clinical service offered to patients for identification of HLA
Class I and Class II subtypes. Such testing allowed us to identify B27 positive
patients who had earlier been clinically diagnosed to have ankylosing
spondylitis. PBMCs were collected from five B27 patient volunteers suffering
from the disease, for cell ELISA testing with each scFv antibody from a panel of
about 12 antibodies. The results reported for each antibody thus show the mean
and error bars for five separate samples from five distinct B27 positive
individuals diagnosed to have ankylosing spondylitis. Separately, B27 negative
individuals were identified from amongst healthy volunteers being tested for
their HLA Class I subtype. PBMCs were collected from five healthy B27
negative individuals for cell ELISA testing, as negative controls, and the results
reported are for five distinct samples. However, in regard to the samples for B27
positive individuals who are diagnosed to have not yet developed the disease, itFig. 1. Gel filtration chromatograms of HMW B27 obtained on an analytical Superd
demonstrating that the HMW population does not unfold/dissociate upon reduction
volume in panel B owe to minor differences in the DTT concentration in the sample a
with β2m and peptide on the same column (panel C) is characterized by elution of th
HMW B27 is designated by peak 1, HMW β2m by peak 2, while peaks 4 and 5 repmay be appreciated that such individuals are difficult to come by in a hospital
environment. Therefore, the five samples were drawn from only three healthy
individuals who were clearly asymptomatic but found to carry the B27 antigen,
as healthy B27 positive controls for cell ELISA testing, with PBMCs from two
of these individuals being used on more than one occasion. The procedures
involving patients (including issues concerning informed consent) were
followed after ratification by the institute ethics committee.
2.13. Statistics
Five independent experiments were performed for cell ELISA studies with
each of the four antibodies, I3G, I9D, J2A and I3H. Data were expressed as
mean±standard deviation. Student's unpaired t-test was performed for com-
parison of data points, with p less than 0.05 being considered to be significant.
3. Results
When recombinant β2m-free B27 samples are prepared
under conditions favoring oxidative formation of disulfides,
homodimeric B27 constitutes only a minor fraction (b10%) of
any such β2m-free B27 population, with most of the folded
population consisting of high molecular weight (HMW) species
[11]. This HMW material has not been previously tested to
examine whether it contains structured chains resembling those
within either FHC clusters, or within regular heterotrimeric
β2m- and peptide-containing B27 complexes on cell surfaces.
3.1. Non-disulfide dependent existence of HMW species
As seen in Fig. 1A, gel filtration analysis carried out after
refolding of chains purified under denaturing conditions shows
that no homodimeric population is detectably formed in the
refolded protein through simple air oxidation. Instead, the entire
protein population elutes at∼0.95 ml from a SMART Superdexex 200 column in the absence (panel A), and presence (panel B) of 5 mM DTT,
of disulfide bonds with DTT. The dips in the chromatogram at ∼2.0 ml elution
nd running buffer. The gel filtration chromatogram of the complex of HLA-B27
e complex at 1.54 ml (peak 3) corresponding to a molecular weight of 47 kDa.
resent monomeric and low association-status β2m.
Fig. 2. Far-UV CD spectra of (A) HMW-B27 at 25 °C (—), and 95 °C (- - -),
demonstrating that the protein has an inordinately high secondary structural
content, as well as high thermal stability. (B) trimeric complex of HLA-B27 with
β2m and peptide at 25 °C (—), and 95 °C (- - -), clearly showing that the
complex undergoes thermal melting in response to increase in temperature.
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this suggests a molecular weight ≤300,000 Da for HMW B27.
It is with this HMW protein population that further work
reported in this paper was carried out.
HMW B27 was equilibrated with 5 mM DTT and chro-
matographed on the same Superdex 200 column pre-equili-
brated with buffer containing 5 mMDTT. As Fig. 1B shows, the
presence of this high concentration of DTT did not result in
elution of smaller molecular weight species; rather, elution
continued to be seen close to the void volume of the column, at
the exact same elution volume earlier obtained without DTT.
The dip seen in the later section of this chromatogram (at 2.0–
2.1 ml) can be ascribed to the negative absorption resulting from
there being a marginally higher concentration of DTT in the
running buffer as compared to the sample, despite efforts to
make both equivalent to 5 mM DTT. Generally, DTT concen-
trations of 1–2 mM are sufficient to reduce all the disulfides in a
protein, and a concentration of 5 mM DTT is used for the
reduction of partly buried disulfides (although, of course, fully
buried disulfides could resist reduction even with this
concentration of DTT). The fact that the HMW species does
not disassemble in the presence of 5 mM DTT to release any
distinct and detectable lower molecular weight forms (eluting at
volumes ≥0.95 ml) suggests that even if disulfide bonds exist
within HMW B27 when it is formed, such bonds may not be
critical for the adoption and retention of the oligomeric form. To
test this further, we carried out another set of experiments in
which HMW B27 was subjected to electrophoresis under both
denaturing (SDS-PAGE) and non-denaturing (native) condi-
tions after being prepared for electrophoresis through treat-
ment with different combinations of inclusion, or omission, of a
denaturing agent (1% SDS), a reducing agent (5 mM DTT) and
heat (boiling, or lack thereof). The results are shown in Fig. S3
(Supplementary data). Briefly what electrophoresis assays is
whether the HMW B27 remains in the well of the gel, or at the
interface of the stacking and resolving gels unable to enter the
gel when no denaturing, or reducing, influences are used (i.e.,
whether it is a soluble aggregate), and also whether it enters the
gel to migrate at its expected position, when denaturing and/or
reducing influences are used. In both native and SDS-PAGE
experiments, inclusion or omission of 1% SDS in the sample
buffer was used, regardless of the fact that the running buffer in
SDS-PAGE contains a lower concentration of SDS (0.1%)
whereas no SDS is present in native electrophoresis. The results
show: (i) SDS alone cannot disassemble the HMW form of B27
(lanes A2, A3, B2 and B3); (ii) when SDS is used in com-
bination with DTT, HMW is dissociated to a significant extent
even without boiling of samples (lanes A6 and B6); (iii) DTT
treatment needs to be combined with either SDS treatment
(lanes A6, B6) or with boiling of samples (lanes A9, B9) to
effect a significant extent of dissociation of HMW B27. Based
on the chromatographic and electrophoretic data, therefore, it
may be concluded that noncovalent interactions such as hydro-
phobic interactions, electrostatic interactions and hydrogen
bonding must also play a role in holding the HMW form
together, in combination with disulfide bonding. To summarize
this result, we do not propose that our gel filtration and electro-phoretic data excludes the existence of disulfide bonds within
HMW B27; the data merely establishes that reduction of
disulfides does not lead to complete disassembly of HMW B27
into smaller forms unless reduction is combined with some
other structurally-destabilizing influence such as heat or a
denaturant like SDS. Thus, we conclude that HMW B27 must
be predominantly stabilized by noncovalent interactions. As to
the nature of such interactions, we have earlier speculated that
HMW B27 could consist of structured B27 chains (possessing
native-like structure), which bind, in intermolecular fashion, to
the residues 169–181 of neighboring B27 molecules [19].
These and other models will doubtlessly be tested, as HMW
B27 is studied further. As a control, it may be noted that in
contrast to the behavior of HMW B27, the regular trimeric
complex of B27 with β2-microglobulin and a nonameric pep-
tide (see Materials and methods) elutes at 1.54 ml (Fig. 1C)
corresponding to a molecular weight of 47 kDa.
3.2. Inordinately high secondary structural content in HMWB27
The far-UV CD spectrum of the β2m-free HMW B27 is
shown in Fig. 2A. The protein is clearly seen to have a spectrum
characteristic of very well formed secondary structure, with
Fig. 3. Fluorescence emission spectrum of the HMW HLA-B27 at 25 °C (—),
demonstrating that burial of tryptophan residues in the protein's interior leads to
its emission peaking at 346 nm, rather than at 353 nm as might have been
expected for a form lacking tertiary structure. The same spectrum at 98 °C (- - -)
shows no change in emission wavelength, confirming the retention of tertiary
structure even at high temperatures. The y-axis shows the fluorescence emission
intensity in arbitrary units as is standard practice in fluorescence spectroscopy.
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presence of negative band maxima at 222 and 208 nm) and β
sheets (detected through measurement of the intensity of the
negative signal at 218 nm, relative to the intensity at 222, and
208 nm). For comparison, the far-UV CD spectrum of the B27
heavy chain, in complex with bound peptide ligand and β2m is
shown in Fig. 2B; it may be noted however that as the estimation
of protein concentration in solutions of the complex cannot be
done accurately, the data for the complex is shown in terms of
raw ellipticity, rather than as mean residue ellipticity. The
crystallographically-determined structure of the trimeric HLA
B27 complex is known to contain both types of secondary
structure [20]. Structural analysis reveals that about 82 out of
276 chain residues are α helical (i.e., about 30% of all residues),
whereas about 126 residues make up strands that go to make β
sheets (i.e., about 45% of all residues). The remaining residues
formβ turns, and various other structures including both ordered
(but irregular) and disordered structures or ‘randomly coiled'
structures. To compare these figures to the estimated secondary
structural content of HMW B27, we analyzed its CD spectrum
after conversion of data to mean residue ellipticity. It may be
noted here that rigorous analysis of such a CD spectrum, done in
order to determine the percentages of chain length constituted by
various secondary structures, ordinarily requires the availability
of ellipticity data in the full range of 250–180 nm. However, data
over this entire range is difficult to obtain for such samples,
because HMW species scatter short wavelength radiation very
effectively on account of their multimeric status and large hy-
drodynamic volume, leading to unacceptably poor signal/noise
ratios in the 190–180 nm region. Fortunately, however, methods
which work with data collected over smaller ranges are
available; therefore, we attempted analysis using data collected
between 250 nm and 190 nm, using a neural network-based
approach available as a service on the internet [21]. The CD
spectrum at 25 °C suggests that, to a first approximation, HMW
B27 has over 50% of its residues in α helical structure, with the
remaining chain length adopting β sheets and other structures.
This indicates that the B27 chain has somewhat more helical
structure in the HMW species formed in the absence of β2m
(50% of the chain) than in the presence of β2m (30% of the
chain, as stated earlier), which definitely rules out any net lower
folded status resulting from the absence of β2m.
Where does this extra helicity come from? We suspect that
tracts of one of the β sheet-rich regions of B27 that are no longer
engaged in interactions with β2m may have undergone
transformation into helical structure(s), possibly aided by the
proximity of other misfolded B27 chains in the HMW species.
Since, at least in principle, it remains possible for secondary
structural content to exist in a chain even without the existence
of widespread tertiary structural contacts (especially as seen in
molten globule-like conformations), it was necessary to further
examine these HMW species for tertiary structural content.
3.3. HMW B27 has tertiary structure
The fluorescence emission spectrum of β2m-free B27 is
shown in Fig. 3. As is well-known, the wavelength of maximalemission (λmax) of a protein is a measure of its folded or unfolded
state. The indole side chain of the dominating fluorescent
residue, tryptophan (Trp), is extremely sensitive to the polarity
of its immediate environment. Thus, Trp emission displays a
blue shifting of λmax from the characteristic 353 nm shown by
free Trp (or by Trp exposed to aqueous solvent, e.g., in unfolded
proteins), to significantly shorter wavelengths upon burial of Trp
residues within the interior of a folded protein. A blue-shifted
λmax is diagnostic of burial of tryptophans accompanying struc-
ture formation. Fig. 3 shows that HMW B27 has a λmax of
346 nm whereas molten-globular HMW B27 may have been
expected to have a λmax of 353 nm, just like any unfolded
protein. Therefore, emission of HMW B27 at 346 nm is clearly
indicative of the existence of tertiary structure. The question that
now arises is whether this tertiary structure of HMW B27 is
native-like, to any degree.
3.4. The tertiary structure of HMW B27 is partly native-like
and partly non-native-like
Short of determining the actual three-dimensional structure
of a protein by X-ray crystallography, the best approach to
examine it for native-like structural content is to probe it with
conformation-specific antibodies that bind only to native-like
conformations (preferably adopted by discontinuous stretches
of polypeptide sequence) and not to sequence-specific epitopes
that can be bound even within a grossly unfolded antigen. One
such antibody, described well in the literature, is w6/32. This
antibody binds to a structural epitope constituted of sequences
assembled from the alpha 1 and/or alpha 2 domains of the Class
I MHC chain [13,22], and is thought to bind only to Class I
MHC polypeptides in native form as a part of a complex with
β2m [23]. As the histogram in Fig. 4 shows, we find that w6/32
binds to HMW B27, indicating that the w6/32 antibody-binding
regions of the α1 and α2 domains are folded as well as correctly
assembled. As is well-known, these two domains together give
rise to the peptide-binding cleft in MHC. It may be noted that
Fig. 4. The histogram represents results of ELISA, using the antibody w6/32
against a control sample (no addition of antibody), two non-specific proteins
(ovalbumin and BSA), the HLA-B27 complex, and HMW-B27. The figure shows
very efficient binding of this well-known conformation-specific antibody to HMW
B27 as well as to the trimeric complex of HLA-B27 with β2m and peptide,
indicating that the alpha 1 and alpha 2 domains are folded as well as correctly
assembled in a native-like conformation. The y-axis shows the optical density at
450 nm.
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homodimeric, β2m-free form of B27, with this binding being
taken to be evidence that the homodimer maintains some
conformation of its peptide-binding groove [11,24]. Clearly,
therefore, by the same criterion, the binding of the w6/32
antibody to HMW B27 indicates that this form also maintains
some conformation of the peptide-binding groove.
However, it must be noted that the above result provides no
information regarding the rest of the B27 molecule. Therefore,
we decided to select antibodies against HMW B27 through the
bio-panning of a phage-display antibody library, in order to use
antibodies pre-selected for binding (through bio-panning) to
conformationally probe the B27 chain in both its HMW and
ternary complex forms. Phages displaying scFv antibodies
[96 each from bio-panning of the Tomlinson I and J libraries
(obtained from theMRC, UK)] were picked after three rounds of
bio-panning and amplification. In a re-confirmation of the
screening results obtained from this library, the bulk of these
phages were observed to bind to HMW B27 through phage
ELISA (Fig. S1, Supplementary data). After this, the phages
were turned into phagemids through transformation of phages
into bacterial cells designed to produce and secrete soluble scFv
antibodies. The supernatants from 192 clones (96 each picked
from screening of I and J libraries), which contain soluble scFv
antibodies were then used to perform ELISA experiments for
binding to HMW B27. A total of 24 clones were observed to
contain soluble antibodies capable of binding to HMWB27 (the
fact that this number is lower than 192 is not surprising because it
is possible that the recognition of HMW B27 by the remaining
antibodies in the phage ELISA experiments was dependent on
the scFv antibodies remaining in fusion with the phage pIII coat
protein, and dependent on packing of the folded antibody against
the phage). Fig. 5 shows the ELISA assay for the 192 clones, in
which 24 clones show binding values above the background.
Information concerning which of the extracts shows HMW-
B27 binding was then re-confirmed through a fresh round of
ELISA, and this information was then used to purify periplasmicextracts of antibodies from each of the 24 clones. Unfortunately,
at this point, four of the clones could not be revived, and so we
proceeded with soluble antibodies from only 20 clones. These
antibodies were again tested for binding to HMWB27, as shown
in Table 1, and all were re-confirmed to bind to the HMW form.
Next, these antibodies were examined for binding to the ternary
complex of the HLA B27 heavy chain with β2m and nonameric
peptide. It may be noted that the generation of this complex
had been previously standardized for other experiments (see
Materials and methods); here, the complex was bound to the
microtitre plate in such a manner that the same amount of B27
heavy chain was effectively used for immobilization in each
well, regardless of whether ELISA plates were prepared through
coating of the HMW form of B27, or with the ternary complex
(marked HMWor TC respectively in Table 1). Thus, discounting
for problems of access to epitopes, the same amount of B27
heavy chain protein was used to cross-compare the binding of
the scFv antibodies raised against HMW B27, to the ternary
complex. Table 1 shows the relative binding of these 20 HMW
B27-binding scFv antibodies to ternary complexes of B27 and to
HMW B27. Column 5 in Table 1 shows the fold excess of
ELISA signals of HMW B27 binding over that of binding of the
ternary complex (TC) by the antibodies, as the ratio of the raw
absorption signals obtained with the two forms. It may be noted
that the negative control in which primary antibodies were not
added during the procedure gave a value below 0.07 for both
anti-HMW ELISA and anti-TC ELISA. The ratio of OD
readings for the binding of scFv to HMW vs. that of binding
to the ternary complex showed that 7 out of 20 clones exhibited
preferential binding to HMW as determined by ratio of OD
readings greater than 2 standard deviations (95% confidence
interval) from a background average represented by the lowest
13 readings (3.707±2.387). Therefore, in assessing fold excess
of anti-HMW signals over corresponding anti-TC signals, we
took any value up to 8.4:1 to be indicative of comparable binding
of the two forms. Where fold excess values were almost 8.4:1, or
more, we took this to indicate differential binding of the two
forms.
Separately, the 20 scFv antibodies were also used in western
blot experiments to examine whether they can bind to epitopes
on the B27 heavy chain, following denaturation on SDS-PAGE
and partial, or incomplete, denaturation. A total of 14 of these
clones recognized the B27 heavy chain in the western blot
(Fig. S2, Supplementary data).
Our analysis of the data used the following criteria, to obtain
the results summarized in Table 1 in regard to content of native-
like and non-native-like conformational epitopes:
(i) An antibody could bind, in principle, to either: (a) a
continuous stretch of amino acid residues recognized in a
particular folded conformation, or a non-folded, extended
conformation (i.e., a sequence epitope), or to (b) a combi-
nation of two or more discontinuous stretches of amino acid
residues coming together in the folded structure to give rise
to a uniquely structured epitope that would certainly not be
expected to exist in unfolded protein molecules (i.e., a con-
formational epitope), unlike a sequence epitope presented by
Fig. 5. Histograms showing ELISAvalues recorded with soluble scFvs (expressed in HB2151 cells) binding to coated HMWB27 in case of 96 clones from A) library I
and B) library J respectively. The y-axis shows the optical density at 450 nm.
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course, B27 polypeptides could potentially refold upon SDS
removal during the western-blotting procedure to give rise to
partially-folded, B27 chains showing up on western blots,
we chose to assume the stringent criterion that antibodies
showing binding on western blots bind mainly to sequence
epitopes and not to conformational epitopes, as there is a
higher likelihood of this being the case due to non-folding, or
improper folding, of chains. According to this criterion, the
antibodies that bind to sequence epitopes are I1H, I2A, I2C,
I2H, I3A, I3H, I11E, J2A, J2B, J3E, J3F, J3H, J5E, and J6F
(see data in Fig. S2, Supplementary data).
(ii) According to the reasoning given above, antibodies
giving positive results in western blot, as well as comparable
values of raw data in anti-HMW ELISA and anti-TC ELISA
could be taken to bind to sequence epitopes that are exposed
on the surface of both the HMW form, and the TC form. Ten
antibodies from amongst those recognizing sequence
epitopes were found to recognize both HMW and TC with
a fold excess value of anti-HMW signals over anti-TC
signals of less than 8.4:1. These were, respectively, I1H, I2A,
I3A, I11E, J2A, J2B, J3F, J3H, J5E, and J6F (Table 1). Note
that I2A showed a value of 8:1 (less than 8.4:1) and is
technically also in this group.
(iii) Antibodies that gave positive results in western blot, and
positive values in anti-HMW ELISA but not in anti-TC
ELISA (i.e., with fold excess values of 8:4 or higher) were
taken to bind to sequence epitopes exposed on the surface of
only the HMW form, and not the TC form. These were,respectively, I2C, I2H, I3H and, most prominently, J3E. For
the last of these, the fold excess was 39:1, indicating that this
epitope is very definitely exposed on HMW B27 and buried
in the B27 TC. It may be noted here that the reverse situation
cannot obtain, i.e., there can be no sequence epitope-recog-
nizing antibodies that give only anti-TC signals but no anti-
HMW signals since, in the first place, the antibodies were
selected for anti-HMW binding.
(iv) The antibodies that do not give positivewestern blot results,
but give positive results in ELISA experiments, can be taken to
bind to conformational epitopes. Of these, three antibodies,
I4B, I5A and J1A were found to give signals of comparable
intensity in anti-HMW and anti-TC ELISA experiments,
indicating that they bind to a conformational epitope present
on both HMW B27 and the B27 ternary complex.
(v) Three scFv antibodies, which gave negative results in
western blot experiments, gave much higher intensity signals
in anti-HMW ELISA experiments (i.e., a fold excess N8:4)
than in anti-TC ELISA experiments. These were taken to
bind to conformational epitopes displayed on HMW B27
that could be specific to HMW B27. These are the antibodies
I3G, I9D and J8D.
3.5. Thermostability of structure
Fig. 2A showed that in the case of the HMW B27 chain there
is no dramatic change in the CD signal strength at any wave-
length in the range of 250–190 nm, upon increasing of tem-
perature to 95 °C, which means that negligible thermal melting
Fig. 6. Kinetic stability of HMWHLA-B27 to proteolytic cleavage by trypsin at
37 °C, using a trypsin:B27 ratio of approximately 1:6000. Lane 1 shows
molecular weight markers. Lane 2 shows a trypsin-lacking control sample of the
protein incubated overnight. Lanes 3, 4 and 5, respectively show products
resulting from 1, 2 and 3 h of incubation respectively. Lane 6 shows products
resulting from overnight incubation with trypsin. In lane 2, a certain amount of
degradation has occurred in the control sample during overnight incubation
without protease inhibitors.
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native-like levels of secondary structure even at this high
temperature. A comparably high temperature of 98 °C was
attained and used, for fluorescence measurements, with the help
of fluorimetric and Peltier-based high temperature accessories
on a Jasco CD spectropolarimeter. The λmax of emission at
98 °C was also found to be 346 nm (Fig. 3), and not 353 nm as
should have been the case if the HMW B27 had undergone
thermal unfolding. This further confirms that the protein retains
both secondary and tertiary structure at very high temperatures.
In direct contrast, structural melting could clearly be observed to
occur upon heating of trimeric complexes of HLA-B27 with
β2m and peptide, as seen in the data in Fig. 2B. When melting
was monitored through observation of changes in ellipticity at
208 nm as a function of increasing temperature (data not
shown), melting could be seen to have been initiated between
65 and 70 °C. Notably, previous studies [25,26] of the thermal
melting of HLA-B27 complexes incorporating B2705 have also
reported a melting temperature in the same range, corroborating
our results with the complex.
3.6. Proteolytic evidence for a tight structure
The B27 chain is expected to generate exactly 33 fragments
upon limit-digestion by trypsin, with the largest such fragment
being 24 residues (∼2600 Da) long. Therefore, any evidence
indicating that proteolysis does not proceed to completion, or
that a chain segment longer than this survives digestion, may be
taken to be evidence of the existence of autonomously-
stabilized sub-structures, since only formed structures could
bury scissile peptide bonds away from trypsin. As can be seen
in Fig. 6, many ‘survivor’ fragments remain upon overnight
proteolysis, including some that are almost the size of lysozyme
(14.4 kDa). Therefore, it may be concluded that one or more
subdomain(s) of β2m-free B27 survive limit-trypsinolysis after
initial proteolytic release from HMW B27. One of these
fragments, surviving the overnight digestion with trypsin
(∼12 kDa) was examined through N-terminal sequencing and
found to have the residues F, I, T, V, G, Y at its N-terminus,
which corresponds to the stretch initiating at residue 23 of the
362 residues-long B27 chain. Since this peptide is only 12 kDa
in size, its C-terminus must lie some one hundred or more
residues further away, from residue 23, towards the C-terminus
of the B27 chain. Analysis of the trypsinolysis sites in the B27
chain suggests that the C-terminus of this fragment must
constitute the sequence N-DAYDGK-C, i.e., that the survivor
fragment must end with residue 122, since the sequence
spanning the trypsinolysis sites at residue positions 22 and
122 of the B27 chain measures up to exactly 11,792 Da from
sequence analysis, which is the closest to the size of 12 kDa.
The closest competing sites at residue positions 112, and 146,
respectively, would have resulted in fragment masses of
10,639 Da (considerably smaller than the observed size), and
14,446 Da (larger than the observed size). Thus we may
conclude that the most structurally stable region of HMW B27
is the segment from residue 23 to residue 122, spanning the
alpha 2 domain.3.7. Select scFv anti-HMW antibodies discriminate between
ankylosing spondylitis (AS) patients and healthy volunteers
About twelve scFv antibodies (including those that bind
specifically to HMW B27) were tested, in cell ELISA
experiments conducted with human peripheral blood mono-
nuclear cells (PBMCs) isolated from B27 negative, and B27
positive individuals (both from healthy individuals and those
clinically diagnosed to have AS). These experiments allowed us
to explore the presence of HMW-like forms of B27 on cell
surfaces and simultaneously assess the importance of such forms
to disease. With three of these antibodies significantly (3–5 fold)
larger ELISA values were obtained with AS patients as
compared to healthy B27 negative and B27 positive individuals
(Fig. 7) whereas with the remaining antibodies comparable
values were obtained for all three classes of samples (data not
shown), except for I3H which, like the other antibodies, showed
an insignificant difference between healthy B27 individuals and
patients with ankylosing spondylitis, but at the same time
showed a statistically significant difference between individuals
who were negative for B27 and those positive for B27. This
antibody, therefore, was used as a B27-reactive, but non-patient
distinguishing control for the cell ELISA experiments, together
with I3G, I9D and J2A. I3G and I9D, showed about 3–5 fold
higher values with samples from AS patients than with other
samples. The clone for the third HMW-specific antibody, J8D,
showed poor expression levels at this stage of the study and
could not be included in the cell ELISA experiments.
Interestingly, J2A, also emerged as a diagnostic indicator of
diseased status, suggesting that it may have been unfairly
rejected as an HMW-specific antibody by our stringent criterion.
It has been mentioned earlier that a western blot positive
antibody could still involve a conformational epitope, since it is
Fig. 7. Cell ELISA assay data with four scFv antibody clones, three of which
showed differences between B27 negative, B27 positive but healthy, and B27
positive and diseased (ankylosing spondylitis) individuals. The fourth antibody,
I3H, which distinguishes between B27-positive and B27-negative cells like the
B27-reactive antibody, ME1, was used as a control.
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SDS-removal, particularly given that the recombinant B27 chain
in the gel would undergo refolding (of whatever sort) in the
absence of β2m. Thus we conclude that the J2A antibody too,
like the I3G and I9D antibodies, binds to a conformational
epitope specifically displayed on HMW B27, since its results in
cell ELISA experiments with AS patients are a little over 2-fold
higher thanwith other samples, similar to the differential binding
of J2A to HMW B27 which is a little over 2-fold higher than to
TC. However, in the discussion over the ability of J2A to
distinguish AS patients, we must not forget that two scFv
antibodies identified by us to bind specifically to HMW B27
(over 8.5 fold higher than to B27 in TC form) also similarly
distinguish samples from B27 positive AS patients from other
B27 positive and negative samples, to an even greater degree
than J2A. This simultaneously suggests that HMW B27 is
present on cell surfaces, and that it may also be associated with
disease etiology. The statistical significance of these results was
examined by applying the Student's unpaired t-test to the same 5
independent cell ELISA experiments for which mean and
standard errors are shown in Fig. 7. The obtained p values
describing the significance of differences in the binding of the
four antibodies to healthy B27 individuals versus ankylosing
spondylitis patients were 0.0014 (I9D), 0.0001 (I3G), 0.0008
(J2A), and 0.0988 (I3H). Similarly, the obtained p values
describing the significance of differences in the binding of the
four antibodies to B27-negative versus B27-positive individuals
were 0.5 (I9D), 0.0026 (I3G), J2A (0.0448) and 0.0101 (I3H).
Given that p values b0.05 are statistically significant, two
conclusions can be made from these analyses: (i) I3H is anME1-
type antibody that is B27-reactive. (ii) That the differential
binding of I9D, I3G and J2A to healthy B27-positive individuals
and ankylosing spondylitis patients is statistically significant.
4. Discussion
Here we discuss our results in the light of what is already
known about β2m-free B27, and especially about HMW B27, in
the published literature. As already mentioned, the bulk of thepopulation that is found in the form of soluble protein – even in
oxidation-favoring refolding environments – consists of HMW
species of indeterminate association number [11]. The bulk of
research attention thus far has, however, been paid to a population
of homodimers which, as reported in this paper, is not seen in
experiments that do not deliberately favor oxidation. Presumably,
this lack of attention is because HMW-B27 has been assumed to
consist of unstructured, or poorly structured, aggregates of little
importance to disease mechanisms. Aggregates have traditionally
been neglected as randomly-formed agglomerates of unfolded
chains. However, as is well-known, they are increasingly being
reported to be of importance to disease mechanisms. It is our case
that the same may be applicable to HLA and disease.
Once a chain has engaged in HMW formation, it is likely that
no scope remains for it to form a homodimer. In the earliest
studies in which HMW-B27 was observed [11], it was found to
display the mobility expected of a B27 monomer on SDS-PAGE
only when samples were boiled in the presence of SDS under
reducing conditions prior to electrophoresis. When reducing
agents ordinarily used for electrophoresis were deliberately
excluded from the sample loading buffer (prior to boiling of
samples for SDS-PAGE), the HMW species did not dissociate to
generate the expected SDS-bound monomeric B27 species
during electrophoresis. A possible rationalization of this result is
that unfolding of the associated B27 chains was occurring upon
boiling in the presence of SDS, but that the dissociation of such
chains into SDS-bound monomers was not occurring, because
such dissociation was precluded (mainly by disulfide bonds that
failed to be reduced). This indicates, of course, that disulfide
bonds do exist in the HMW species and we do not contest this.
However, very importantly, when cysteine 67 was replaced by
serine through genetic manipulation [11], the minority popula-
tion of homodimers could be no longer detected. The entire
population could be seen to have transformed into HMW B27.
This suggests two very important insights, namely: (i) that the
formation of homodimers requires the formation of disulfide
bonds involving Cys67, and (ii) that the formation of the HMW
species does not require the formation of disulfides involving
Cys67, even though such disulfides are clearly formed. The only
conceivable structural-biochemical rationalization of this obser-
vation, for the moment, stems from what we have proposed in
our recent hypothesis [19]: namely that noncovalent as well as
covalent interactions exist in both the homodimer and the HMW
species, but that disulfides play a more crucial role in stabilizing
homodimers, and only an incidental role in stabilizing HMW
species. Only when Cys67–Cys67 disulfide bonds form, do the
reciprocally bound chains in a homodimer become sufficiently
stabilized. When Cys67 is mutated to Ser67, there aren't enough
interactions available to prevent dissociation of homodimers.
Therefore, all molecules form the more (autonomously) stable
HMW species that does not depend on Cys67–Cys67 disulfides
for its stability. As a consequence, Ser67 mutants form only
HMW species, and no homodimers. Such species are amenable
to being unfolded and dissociated upon being boiled in the
presence of SDS (even in the absence of reducing agents)
because they have no disulfide bonds that need to be reduced
prior to dissociation. This conclusion gets additional support
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species do not unfold, or dissociate, when disulfides are reduced
by 5 mM DTT, because there is now neither SDS nor high
temperature available to break noncovalent interactions, and
cause chain unfolding. In addition, electrophoretic experiments
reported in this paper which include also the differential treat-
ment of boiling, or lack of boiling, of samples reveal that DTT
alone does not manage to completely dissociate HMW B27 and
that accompanying denaturing influences are required in the
form of either heat, or the presence of SDS. Therefore, it would
appear that HMW B27 is principally stabilized by noncovalent
interactions amongst structured B27 chains, with disulfide
bonding involving Cys67 being merely incidental to the for-
mation of this species.
In this paper, we have firstly provided evidence suggesting
that this form of B27 contains alpha 1 and alpha 2 chains folded
and assembled correctly enough to generate conditions for the
immune recognition of a conformational epitope recognized by
the w6/32 antibody. A sizeable fraction of this region is also
shown to resist internal proteolysis by trypsin. Notably, the α1
and α2 domains assemble to give rise to the peptide-binding
cleft of any Class I MHC molecule. Therefore, our results
suggest that HMW B27 may contain peptide-binding clefts.
Certainly, the structural content of HMW B27 and the extreme
stability of this form of B27, taken together with the w6/32
binding data, indicate that B27 chains within HMW B27 are
folded, and suggest that the domains of this molecule may be
assembled into a native-like structural format.
The data with the scFv antibodies clearly demonstrates that
sections of HMW B27 are native-like in structural content,
whereas other sections are non-native-like. We identified at least
three antibodies that bind to a conformational epitope on both
HMW B27 and the B27 ternary complex, and at least ten
antibodies that bind to sequence epitopes that are present on the
surfaces of both forms and which may also conceivably be bound
in the same conformation. These results suggest that there are
significant commonalities between the structural organizations of
the B27 chain in the two forms. At the same time, our results with
the scFv antibodies demonstrate that there are also significant
differences in the folding of the chain in the two forms. We
identified at least four antibodies that bind clearly only to a
sequence epitope, and three antibodies that bind to conforma-
tional epitopes presented only by the surface of HMW B27 and
not by TC B27. No antibodies that bind only to conformational
epitopes on B27 TC were identified because the phage display
antibody libraries were screened for binding to HMW B27. We
did not separately screen libraries for binding to B27 TC because
of the potential infeasibilities of separating and distinguishing
between antibodies binding to the B27 HC and β2m.
Using cell ELISA experiments we show that two HMW
conformation-specific antibodies (I3G and I9G) and one anti-
body that may be HMW conformation-specific even though it
shows positive results with western blots (J2A) bind to cells of
ankylosing spondylitis patients, but not to equivalent levels to
cells from healthy B27 positive, or B27 negative individuals.
These results hold great promise in further elucidation of the role
of B27 misfolding to HMW forms in the etiology of disease.If HMW B27 chains are indeed somewhat native-like, as
suggested by these studies and if they possess assembled α1 and
α2 domains forming peptide-binding clefts, are these clefts
occupied, and if so with what? We have previously argued that
an unstructured section of the B27 chain can separate away and
bind to a B27 peptide-binding cleft to give rise to intermolecular
cross-display. Such intermolecular swapping of sections has
been reported in other soluble and insoluble HMW systems [27–
30], and it is conceivable that HMWB27 also swaps other folded
sections between neighboring molecules, i.e., sections that re-
main to be discovered (such as e.g., folded α2/α3 sub-domains).
Certainly, such mechanisms could generate and stabilize multi-
mers in a disulfide-independent fashion, and we have shown that
the native-like B27 chains are indeed assembled into disulfide-
independent multimers, even though such multimers do clearly
contain intermolecular disulfides. We are thus inclined to
suggest that since the bulk of the β2m-free population consists
of HMW B27, this species may be at least as important to the
disease mechanism as the disulfide-bonded homodimer.
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